FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.

Edouard DepardonSalim KanounOlivier HumbertAurélie BertautJean-Marc RiedingerIlan TalJean-Marc VrigneaudMaud LasserreMichel ToubeauAlina Berriolo-RiedingerInna Dygai-CochetPierre FumoleauFrançois BrunotteAlexandre Cochet

Published in: PloS one (2018)

Metabolic response evaluation with EORTC criteria and PERCIST gave similar prognostic stratification for metastatic breast cancer treated with a first line of systemic therapy.

Keyphrases

metastatic breast cancer
stem cells
mesenchymal stem cells
cell therapy
bone marrow
drug induced